The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...

An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

A study has suggested that the use of weight-loss jabs may be associated with wider health benefits, including a lower risk ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

Weight loss jabs such as Wegovy may reduce risk of dementia by easing inflammation in the brain, scientists say. The drugs ...